Europe Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031
The Europe Clinical Risk Grouping Solution Market would witness market growth of 12.7% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Clinical Risk Grouping Solution Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $111.2 million by 2031. The UK market is exhibiting a CAGR of 11.8% during (2024 - 2031). Additionally, The France market would experience a CAGR of 13.9% during (2024 - 2031).
The growing need for personalized medicine is having a big impact on the adoption of clinical risk grouping solutions. This is because healthcare practitioners are becoming more aware of the significance of tailoring treatment programs to meet the needs of individual patients to meet their specific needs.
Additionally, personalized medicine, or precision medicine, aims to customize healthcare based on a patient’s genetic makeup, lifestyle, environment, and other personal factors. This approach contrasts with the traditional one-size-fits-all treatment model, which may not be effective for everyone. By focusing on the individual, personalized medicine seeks to enhance the effectiveness of care, reduce the incidence of adverse effects, and improve overall patient outcomes.
Europe's clinical risk grouping solution market is expanding steadily, driven by various factors, including the aging population, rising healthcare expenditures, and the need for more efficient healthcare management systems. In Germany, the aging population is a significant factor driving the demand for clinical risk grouping solutions. According to the Federal Statistical Office of Germany (Destatis), by the mid-2030s, the number of individuals in Germany who are at least 67 years of age will increase by approximately 4 million to a minimum of 20.0 million. The escalating prevalence of age-related chronic conditions, including cardiovascular diseases, diabetes, and dementia, necessitates the more efficient administration of healthcare resources as the population ages.
Based on Product, the market is segmented into Software and Services. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers, and Other. Based on Deployment, the market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. Based on Application, the market is segmented into Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- >Conduent, Incorporated
- 3M Company
- Oracle Corporation (Cerner Corporation)
- Microsoft Corporation (Nuance Communications, Inc.)
- Health Catalyst, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- HBI Solutions
- Lightbeam Health Solutions
- Reveleer
By Product
- >Software
- Services
- >Hospitals & Clinics
- Ambulatory Surgical Centers
- Long Term Care Centers
- Other
- >Private Cloud
- Public Cloud
- Hybrid Cloud
- >Population Health Management
- Chronic Disease Management
- Clinical Decision Support
- Fraud Detection and Prevention
- Others
- >Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Clinical Risk Grouping Solution Market, by Product
- 1.4.2 Europe Clinical Risk Grouping Solution Market, by End-use
- 1.4.3 Europe Clinical Risk Grouping Solution Market, by Deployment
- 1.4.4 Europe Clinical Risk Grouping Solution Market, by Application
- 1.4.5 Europe Clinical Risk Grouping Solution Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities:
- 3.2.4 Market Challenges:
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2023
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar – 2024, Apr) Leading Players
- 4.5 Porter Five Forces Analysis
- Chapter 5. Europe Clinical Risk Grouping Solution Market by Product
- 5.1 Europe Software Market by Country
- 5.2 Europe Services Market by Country
- Chapter 6. Europe Clinical Risk Grouping Solution Market by End-use
- 6.1 Europe Hospitals & Clinics Market by Country
- 6.2 Europe Ambulatory Surgical Centers Market by Country
- 6.3 Europe Long Term Care Centers Market by Country
- 6.4 Europe Other Market by Country
- Chapter 7. Europe Clinical Risk Grouping Solution Market by Deployment
- 7.1 Europe Private Cloud Market by Country
- 7.2 Europe Public Cloud Market by Country
- 7.3 Europe Hybrid Cloud Market by Country
- Chapter 8. Europe Clinical Risk Grouping Solution Market by Application
- 8.1 Europe Population Health Management Market by Country
- 8.2 Europe Chronic Disease Management Market by Country
- 8.3 Europe Clinical Decision Support Market by Country
- 8.4 Europe Fraud Detection and Prevention Market by Country
- 8.5 Europe Others Market by Country
- Chapter 9. Europe Clinical Risk Grouping Solution Market by Country
- 9.1 Germany Clinical Risk Grouping Solution Market
- 9.1.1 Germany Clinical Risk Grouping Solution Market by Product
- 9.1.2 Germany Clinical Risk Grouping Solution Market by End-use
- 9.1.3 Germany Clinical Risk Grouping Solution Market by Deployment
- 9.1.4 Germany Clinical Risk Grouping Solution Market by Application
- 9.2 UK Clinical Risk Grouping Solution Market
- 9.2.1 UK Clinical Risk Grouping Solution Market by Product
- 9.2.2 UK Clinical Risk Grouping Solution Market by End-use
- 9.2.3 UK Clinical Risk Grouping Solution Market by Deployment
- 9.2.4 UK Clinical Risk Grouping Solution Market by Application
- 9.3 France Clinical Risk Grouping Solution Market
- 9.3.1 France Clinical Risk Grouping Solution Market by Product
- 9.3.2 France Clinical Risk Grouping Solution Market by End-use
- 9.3.3 France Clinical Risk Grouping Solution Market by Deployment
- 9.3.4 France Clinical Risk Grouping Solution Market by Application
- 9.4 Russia Clinical Risk Grouping Solution Market
- 9.4.1 Russia Clinical Risk Grouping Solution Market by Product
- 9.4.2 Russia Clinical Risk Grouping Solution Market by End-use
- 9.4.3 Russia Clinical Risk Grouping Solution Market by Deployment
- 9.4.4 Russia Clinical Risk Grouping Solution Market by Application
- 9.5 Spain Clinical Risk Grouping Solution Market
- 9.5.1 Spain Clinical Risk Grouping Solution Market by Product
- 9.5.2 Spain Clinical Risk Grouping Solution Market by End-use
- 9.5.3 Spain Clinical Risk Grouping Solution Market by Deployment
- 9.5.4 Spain Clinical Risk Grouping Solution Market by Application
- 9.6 Italy Clinical Risk Grouping Solution Market
- 9.6.1 Italy Clinical Risk Grouping Solution Market by Product
- 9.6.2 Italy Clinical Risk Grouping Solution Market by End-use
- 9.6.3 Italy Clinical Risk Grouping Solution Market by Deployment
- 9.6.4 Italy Clinical Risk Grouping Solution Market by Application
- 9.7 Rest of Europe Clinical Risk Grouping Solution Market
- 9.7.1 Rest of Europe Clinical Risk Grouping Solution Market by Product
- 9.7.2 Rest of Europe Clinical Risk Grouping Solution Market by End-use
- 9.7.3 Rest of Europe Clinical Risk Grouping Solution Market by Deployment
- 9.7.4 Rest of Europe Clinical Risk Grouping Solution Market by Application
- Chapter 10. Company Profiles
- 10.1 Conduent, Incorporated
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expenses
- 10.2 3M Company
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
- 10.3 Oracle Corporation (Cerner Corporation)
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
- 10.4 Microsoft Corporation (Nuance Communications, Inc.)
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Product Launches and Product Expansions:
- 10.4.6 SWOT Analysis
- 10.5 Health Catalyst, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Product Launches and Product Expansions:
- 10.5.5.2 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
- 10.6 Koninklijke Philips N.V.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.6.5 Recent strategies and developments:
- 10.6.5.1 Product Launches and Product Expansions:
- 10.6.5.2 Acquisition and Mergers:
- 10.6.6 SWOT Analysis
- 10.7 Siemens Healthineers AG (Siemens AG)
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 SWOT Analysis
- 10.8 HBI Solutions
- 10.8.1 Company Overview
- 10.9 Lightbeam Health Solutions
- 10.9.1 Company Overview
- 10.9.2 Recent strategies and developments:
- 10.9.2.1 Partnerships, Collaborations, and Agreements:
- 10.9.2.2 Acquisition and Mergers:
- 10.10. Reveleer
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
- 10.10.2.1 Acquisition and Mergers:
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook